Uniting Against Lung Cancer

Uniting Against Lung Cancer reports $0 revenue and assets, indicating potential cessation of operations.

EIN: 134195464 · New York, NY · Updated: 2026-03-28

$0Revenue
$0Assets
50/100Mission Score (Fair)
Uniting Against Lung Cancer Financial Summary
MetricValue
Total Expenses$2.6M
Net Assets$1.4M
Transparency Score50/100

Is Uniting Against Lung Cancer Legit?

Some Concerns

GoodFiling Consistency
UnknownSpending Efficiency
ModerateTransparency
2 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

About Uniting Against Lung Cancer

Uniting Against Lung Cancer (EIN: 134195464) is a nonprofit organization based in New York, NY. The organization reported total revenue of $0 and total assets of $0 according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Uniting Against Lung Cancer's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

Mid-SizeSize Classification
4Years of Filings
GrowingRevenue Trajectory

Uniting Against Lung Cancer is a mid-size nonprofit, with 4 years of IRS 990 filings on record (2012–2015). Revenue has grown at a compound annual rate of 12.2%.

Key Financial Metrics (2015)

From the most recent IRS 990 filing on record:

Total Revenue$2.9M
Total Expenses$2.6M
Surplus / Deficit+$311K
Total Assets$2.3M
Total Liabilities$906K
Net Assets$1.4M
Operating Margin10.5%
Debt-to-Asset Ratio40.0%
Months of Reserves10.3 months

Financial Health Grade: A

In 2015, Uniting Against Lung Cancer reported a surplus of $311K with revenue exceeding expenses, holds 10.3 months of operating reserves (strong position), has a debt-to-asset ratio of 40.0% (moderate leverage).

Financial Trends

Over 4 years of filings (2012–2015), Uniting Against Lung Cancer's revenue has grown at a compound annual growth rate (CAGR) of 12.2%.

YearRevenue ChangeExpense ChangeAsset Change
2015+2.3%-5.8%-0.3%
2014+5.3%+7.9%+22.6%
2013+31.1%+17.7%+27.0%

AI Transparency Report

Uniting Against Lung Cancer appears to have ceased operations or significantly scaled down, as its latest reported revenue and assets are both $0. This is a critical change from its historical financial data, where it consistently reported revenues between $2 million and $2.9 million and assets exceeding $1.4 million. The organization's financial health, based on the most recent data, is non-existent. Historically, the organization demonstrated reasonable spending efficiency, with expenses generally below revenue, leading to asset growth. For example, in 2015, revenue was $2,947,847 against expenses of $2,636,923. The consistent reporting of 0% officer compensation across all available filings suggests good transparency regarding executive pay, although the lack of NTEE code is a minor transparency drawback. The sudden disappearance of financial activity raises significant concerns about its current status and ability to fulfill its mission.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Uniting Against Lung Cancer with a Mission Score of 50 out of 100 (Fair). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

  • admin: 0%
  • programs: 0%
  • fundraising: 0%

According to IRS 990 filings, Uniting Against Lung Cancer allocates its expenses as follows: admin: 0%, programs: 0%, fundraising: 0%.

Key Financial Metrics (2015)

From the most recent IRS 990 filing on record:

$2.9MTotal Revenue
$2.6MTotal Expenses
$2.3MTotal Assets
$906KTotal Liabilities
$1.4MNet Assets
  • The organization reported a surplus of $311K, with revenue exceeding expenses.
  • Debt-to-asset ratio: 40.0%.

Executive Compensation Analysis

Across all reported periods (2012-2015), Uniting Against Lung Cancer consistently reported 0% officer compensation, indicating that no portion of its expenses was allocated to executive salaries during its active years. This suggests a highly volunteer-driven leadership or a different compensation structure not captured as 'officer compensation'.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Uniting Against Lung Cancer's IRS 990 filings:

  • Latest filing shows $0 revenue and assets, indicating potential organizational failure or cessation.
  • No NTEE code provided, which can hinder categorization and comparison with peer organizations.

Strengths

The following positive indicators were identified for Uniting Against Lung Cancer:

  • Historically maintained positive net income, growing assets from $1.4M to $2.2M between 2012 and 2015.
  • Reported 0% officer compensation across all active periods, indicating efficient use of funds for leadership or a volunteer-driven model.

Frequently Asked Questions about Uniting Against Lung Cancer

Is Uniting Against Lung Cancer a legitimate charity?

Uniting Against Lung Cancer (EIN: 134195464) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 50/100. It has 4 years of IRS 990 filings on record. 2 red flags identified. 2 strengths noted. Financial health grade: A.

How does Uniting Against Lung Cancer spend its money?

Uniting Against Lung Cancer reported its financials in IRS 990 filings. 4 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.

Are donations to Uniting Against Lung Cancer tax-deductible?

Uniting Against Lung Cancer is registered as a tax-exempt nonprofit (EIN: 134195464). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

Where is Uniting Against Lung Cancer located?

Uniting Against Lung Cancer is headquartered in New York, New York and files with the IRS under EIN 134195464.

How many years of IRS 990 filings does Uniting Against Lung Cancer have?

Uniting Against Lung Cancer has 4 years of IRS 990 filings on record at NonprofitSpending. Additional filing years may become available as the IRS releases new data.

What happened to Uniting Against Lung Cancer's operations and assets after 2015?

The latest filing shows $0 revenue and assets, suggesting the organization has either dissolved, merged, or become completely inactive since its last active reporting period in 2015.

Was Uniting Against Lung Cancer financially healthy when it was active?

Yes, during its active years (2012-2015), the organization generally maintained positive net income (revenue exceeding expenses) and grew its assets from $1,461,146 in 2012 to $2,267,497 in 2015, indicating reasonable financial health.

How did Uniting Against Lung Cancer manage executive compensation?

The organization reported 0% officer compensation across all available filings, suggesting a model where officers were not compensated or compensation was categorized differently.

Filing History

IRS 990 filing history for Uniting Against Lung Cancer showing financial trends over 4 years of public records:

Over 4 years of IRS 990 filings (2012–2015), Uniting Against Lung Cancer's revenue has grown by 41.1%, moving from $2.1M to $2.9M. Total assets increased by 55.2% over the same period, from $1.5M to $2.3M. Total functional expenses rose by 19.6%, from $2.2M to $2.6M. In its most recent filing year (2015), Uniting Against Lung Cancer reported a surplus of $311K, with revenue exceeding expenses. The organization holds $906K in liabilities against $2.3M in assets (debt-to-asset ratio: 40.0%), resulting in net assets of $1.4M.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2015 $2.9M $2.6M $2.3M $906K View 990
2014 $2.9M $2.8M $2.3M $1.2M View 990
2013 $2.7M $2.6M $1.9M $888K View 990
2012 $2.1M $2.2M $1.5M $635K View 990

Year-by-Year Financial Summary

  • 2015: Revenue of $2.9M, expenses of $2.6M, and assets of $2.3M (revenue +2.3% year-over-year).
  • 2014: Revenue of $2.9M, expenses of $2.8M, and assets of $2.3M (revenue +5.3% year-over-year).
  • 2013: Revenue of $2.7M, expenses of $2.6M, and assets of $1.9M (revenue +31.1% year-over-year).
  • 2012: Revenue of $2.1M, expenses of $2.2M, and assets of $1.5M.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Uniting Against Lung Cancer:

2015 Filing 2014 Filing 2013 Filing 2012 Filing

Data Sources and Methodology

This transparency report for Uniting Against Lung Cancer is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New York

Explore more nonprofits based in New York with AI-powered transparency reports.

View all New York nonprofits →

Explore Related Nonprofits

Browse by State